Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

NCT06228066 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

45

Enrollment

NIH

Sponsor class

Conditions

Small Cell Carcinoma of the Bladder
High Grade Neuroendocrine Tumors of the Urinary Tract

Interventions

DRUG: Lurbinectedin
DRUG: Avelumab

Sponsor

National Cancer Institute (NCI)